NEW BLOOD TEST CAN DETECT 'TOXIC' PROTEIN YEARS BEFORE ALZHEIMER'S SYMPTOMS EMERGE.
This was a small sample of participants but the outlook is promising.
Hopefully, this soon leads to a blood diagnostic test that can be used for the general public.
Researchers at the University of Washington have developed a laboratory test that can measure levels of toxic proteins called amyloid beta oligomers in blood samples. These oligomers are thought to play a role in the development of Alzheimer's disease, and the test - called SOBA (soluble oligomer binding assay) - was able to detect them in the blood of patients with Alzheimer's, but not in most members of a control group without cognitive impairment. However, SOBA did detect oligomers in the blood of 11 individuals from the control group, all of whom were later diagnosed with mild cognitive impairment or brain pathology consistent with Alzheimer's. This suggests that the test may be able to detect signs of the disease before cognitive impairments occur, which could be important for early diagnosis and treatment. The researchers are now working on developing SOBA into a diagnostic test for oligomers.
Wishing You the Best in Health!
Dr. Lorn Allison